Skip to content

ECCE MEDICAL: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ECCE MEDICAL

BE 0767.377.787
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€20,881
2024 · €50,849-€29,969
Equity
€106,630
2024 · €121,750-€15,119
Cash
€301
2024 · €974-€673
Balance sheet total
€504,400
2024 · €459,403+€44,998

Largest movements

2024 to 2025
Assets
  • Stocks and contracts +€64,305

    up €64,305 (+79.0%), from €81,377 to €145,682

  • Receivables within one year +€30,126

    up €30,126 (+24.5%), from €122,917 to €153,043

    of which Trade receivables: +€71,802

  • Intangible fixed assets -€26,000

    down €26,000 (-15.4%), from €168,893 to €142,893

  • Tangible fixed assets -€22,878

    down €22,878 (-26.8%), from €85,242 to €62,364

Equity and liabilities
  • Short-term financial debts +€130,115

    up €130,115 (+758%), from €17,157 to €147,271

  • Debts after one year -€49,014

    down €49,014 (-30.5%), from €160,775 to €111,761

  • Trade debts -€30,979

    down €30,979 (-54.5%), from €56,809 to €25,831

  • Tax, wage and social debts +€25,889

    up €25,889 (+48.8%), from €53,053 to €78,942

    of which Taxes: +€25,709

  • Current portion of long-term debt -€15,894

    down €15,894 (-32.5%), from €48,929 to €33,035

Income statement
  • Gross operating margin -€40,354

    down €40,354 (-21.8%), from €184,718 to €144,364

  • Financial charges -€9,113

    down €9,113 (-41.4%), from €21,995 to €12,882

  • Financial income +€6,334

    up €6,334 (+731%), from €866 to €7,200

  • Other operating charges +€5,049

    up €5,049 (+28.2%), from €17,927 to €22,976

  • Taxes -€4,799

    down €4,799 (-22.0%), from €21,800 to €17,001

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €50,849
Gross operating margin -€40,354
Staff costs -€1,559
Depreciation -€353
Other operating charges -€5,049
Other operating items -€2,899
Financial income +€6,334
Financial charges +€9,113
Taxes +€4,799
Result 2025 €20,881
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€37,087
Investment +€7,207
Financing +€29,207
Cash 2024 €974
Net result for the year +€20,881
Depreciation +€41,670
Stocks and contracts -€64,305
Receivables within one year -€30,126
Deferred charges and accrued income -€117
Trade debts -€30,979
Tax, wage and social debts +€25,889
Investment in fixed assets (net) +€7,207
Debts after one year -€49,014
Current portion of long-term debt -€15,894
Short-term financial debts +€130,115
Contributions, distributions and other -€36,000
Cash 2025 €301
brings cash intakes cash out
Every line side by side 50 lines
Line Code 2024 2025 Change %
Total assets 20/58 €459,403 €504,400 +€44,998 +9.8%
Fixed assets 21/28 €254,135 €205,257 -€48,878 -19.2%
Intangible fixed assets 21 €168,893 €142,893 -€26,000 -15.4%
Tangible fixed assets 22/27 €85,242 €62,364 -€22,878 -26.8%
Land and buildings 22 €11,121 €13,915 +€2,794 +25.1%
Plant, machinery and equipment 23 €53,748 €42,718 -€11,029 -20.5%
Furniture and vehicles 24 €9,753 €5,731 -€4,023 -41.2%
Leasing and similar rights 25 €10,620 €0 -€10,620 -100%
Current assets 29/58 €205,268 €299,143 +€93,875 +45.7%
Stocks and contracts in progress 3 €81,377 €145,682 +€64,305 +79.0%
Stocks 30/36 €81,377 €145,682 +€64,305 +79.0%
Amounts receivable within one year 40/41 €122,917 €153,043 +€30,126 +24.5%
Trade receivables 40 €46,326 €118,128 +€71,802 +155%
Other amounts receivable 41 €76,591 €34,915 -€41,676 -54.4%
Cash at bank and in hand 54/58 €974 €301 -€673 -69.1%
Deferred charges and accrued income 490/1 - €117 +€117
Total equity and liabilities 10/49 €459,403 €504,400 +€44,998 +9.8%
Equity 10/15 €121,750 €106,630 -€15,119 -12.4%
Contributions 10/11 €10,000 €10,000 = 0.0%
Reserves 13 €50,000 €50,000 = 0.0%
Distributable reserves 133 €50,000 €50,000 = 0.0%
Profit (loss) carried forward 14 €61,750 €46,630 -€15,119 -24.5%
Amounts payable 17/49 €337,653 €397,770 +€60,117 +17.8%
Amounts payable after more than one year 17 €160,775 €111,761 -€49,014 -30.5%
Financial debts 170/4 €160,775 €111,761 -€49,014 -30.5%
Amounts payable within one year 42/48 €176,878 €286,009 +€109,131 +61.7%
Current portion of amounts payable after more than one year 42 €48,929 €33,035 -€15,894 -32.5%
Financial debts 43 €17,157 €147,271 +€130,115 +758%
Credit institutions 430/8 €17,157 €147,271 +€130,115 +758%
Trade debts 44 €56,809 €25,831 -€30,979 -54.5%
Suppliers 440/4 €56,809 €25,831 -€30,979 -54.5%
Advances received on contracts in progress 46 €348 €348 = 0.0%
Taxes, remuneration and social security 45 €53,053 €78,942 +€25,889 +48.8%
Taxes 450/3 €49,515 €75,224 +€25,709 +51.9%
Remuneration and social security 454/9 €3,538 €3,718 +€180 +5.1%
Other amounts payable 47/48 €583 €583 = 0.0%
Remuneration, social security and pensions 62 €31,696 €33,255 +€1,559 +4.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €41,317 €41,670 +€353 +0.9%
Other operating charges 640/8 €17,927 €22,976 +€5,049 +28.2%
Non-recurring operating charges 66A - €2,899 +€2,899
Gross operating margin 9900 €184,718 €144,364 -€40,354 -21.8%
Operating profit (loss) 9901 €93,778 €43,564 -€50,214 -53.5%
Financial income 75/76B €866 €7,200 +€6,334 +731%
Recurring financial income 75 €866 €7,200 +€6,334 +731%
Financial charges 65/66B €21,995 €12,882 -€9,113 -41.4%
Recurring financial charges 65 €21,995 €12,882 -€9,113 -41.4%
Profit (loss) for the period before taxes 9903 €72,649 €37,881 -€34,768 -47.9%
Income taxes 67/77 €21,800 €17,001 -€4,799 -22.0%
Profit (loss) for the period 9904 €50,849 €20,881 -€29,969 -58.9%
Profit (loss) for the period to be appropriated 9905 €50,849 €20,881 -€29,969 -58.9%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.